ocular disease gene therapy (Genetix)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameocular disease gene therapy (Genetix)
Drug Alias NameLentiVue
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular DegenerationEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenetix Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenetix Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsMacular DegenerationEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A